This study will test the effectiveness of lisdexamfetamine medication as a treatment for loss-of-control eating and weight following bariatric surgery. This is a controlled test of whether, amongst non-responders to acute treatments, lisdexamfetamine medication results in superior outcomes compared with placebo.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Loss-of-Control Eating Frequency
Timeframe: From baseline interview at study enrollment to after the 12-week treatment
Loss-of-Control Eating Frequency
Timeframe: From post-treatment to the 6-month follow-up
Loss-of-Control Eating Frequency
Timeframe: From post-treatment to the 12-month follow-up
Body Mass Index (BMI)
Timeframe: From baseline at study enrollment to after the 12-week treatment
Body Mass Index (BMI)
Timeframe: From post-treatment to the 6-month follow-up
Body Mass Index (BMI)
Timeframe: From post-treatment to the 12-month follow-up